New asthma drug enters first human testing phase
Disease control
Not yet recruiting
This early-stage study aims to test the safety and effects of a new investigational drug called ADO-5030 in people with asthma. Researchers will enroll 36 adults with mild-to-moderate asthma to see how the drug affects their breathing during a controlled airway challenge test. Th…
Phase: PHASE1 • Sponsor: Adovate • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC